Effects of Chronic Use of Eyedrops
Chronic use of eyedrops can lead to significant ocular surface changes, medication-specific side effects, and systemic complications that may impact morbidity, mortality, and quality of life, requiring careful monitoring and management strategies.
Local Effects on Ocular Surface
Preservative-Related Effects
- Benzalkonium chloride (BAK) and other preservatives in eyedrops can cause:
Medication-Specific Effects
Prostaglandin Analogs (e.g., Latanoprost)
- Eyelid skin darkening (may be reversible upon discontinuation) 2
- Changes to eyelashes including:
- Increased length, thickness, and pigmentation
- Increased number of lashes
- Misdirected growth of eyelashes 2
- Increased iris pigmentation (may be permanent) 2
Corticosteroid Eyedrops
- Should be limited to short-term use (maximum 8 weeks) 1
- Prolonged use risks:
- Cataract formation
- Intraocular pressure elevation
- Increased susceptibility to infections 1
Antihistamine/Vasoconstrictor Agents
- Chronic use can lead to rebound vasodilation upon discontinuation 1
- May worsen dry eye symptoms with long-term use 1
Systemic Absorption and Effects
Risk of Systemic Complications
- Inadvertent systemic absorption can occur, especially with:
- Improper administration technique
- Lack of nasolacrimal occlusion
- Multiple drop administration 3
- Beta-blocker eyedrops (e.g., timolol) can cause:
- Lightheadedness
- Dyspnea
- Chest pressure
- Faintness
- Exacerbation of heart failure 3
Minimizing Systemic Absorption
- Digital pressure can be applied over the lacrimal sac and puncta after administration 4
- Allow at least 5 minutes between different eyedrop medications 2
- Proper administration technique is crucial to minimize systemic effects 1
Adherence and Administration Challenges
Adherence Issues
- Studies indicate poor adherence to eyedrop therapy, even with instruction and monitoring 1
- Nearly 45% of glaucoma patients take fewer than 75% of prescribed doses 1
- Fixed combinations of medications may improve adherence by reducing the number of drops required 1
Administration Difficulties
- Proper instillation is difficult for many patients 1
- Ability to self-administer worsens with:
- Aging
- Comorbidities
- Disease progression 1
- Nearly half (43-49%) of patients with glaucoma or dry eye disease have at least one comorbid condition that could affect eyedrop self-administration 5
- Patients with multiple conditions that may impair administration have significantly higher odds of requiring eyedrop therapy 5
Management Strategies for Long-Term Use
Improving Administration and Adherence
- Provide repeated instruction and counseling about proper techniques 1
- Create clearly written medication regimens 1
- Consider smartphone reminders and follow-up calls 1
- Link eyedrop administration to activities of daily living 1
Alternative Delivery Systems
- Consider alternative drug delivery systems for patients with adherence issues:
- Punctal plugs
- Fornix rings
- Contact lenses
- Subconjunctival injections/devices
- Intracameral delivery systems 1
- Bimatoprost intracameral implant has been FDA-approved for glaucoma patients with administration difficulties 1
Special Considerations
Contact Lens Wearers
- Contact lenses should be removed prior to eyedrop administration 2
- Lenses may be reinserted 15 minutes after administration 2
- Preservatives in eyedrops may be absorbed by contact lenses 2
Multiple Medication Management
- If more than one topical ophthalmic drug is being used, administer at least five minutes apart 2
- Eye drops must be instilled before applying eye ointment, as ointment affects drop absorption 6
When to Consider Alternative Therapies
- Consider alternative therapies when:
- Patient experiences significant loss of quality of life due to eyedrop side effects 1
- Prolonged corticosteroid therapy (>8 weeks) is required 1
- Patient has physical or cognitive limitations affecting proper administration 5
- Significant risk exists that visual acuity may be reduced due to medication side effects 1
By understanding these effects and implementing appropriate management strategies, healthcare providers can help minimize the negative impacts of chronic eyedrop use while maximizing therapeutic benefits.